欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	MT/H/0218/002
药品名称	Caspofungin Mylan 70 mg powder for concentrate for solution
活性成分	caspofungin acetate 70.0 mg
剂型	Powder for concentrate for solution for infusion
上市许可持有人	Mylan Pharmaceuticals Limited, Damastown Industrial Park, Mulhuddart, Dublin 15, Dublin, Ireland Mylan S.A.S (OLD MAH) 117, Allee des Parcs 69800 Saint Priest Franc
参考成员国 - 产品名称	Malta (MT) Caspofungin Alenicum 70 mg powder for concentrate for solution
互认成员国 - 产品名称	United Kingdom (Northern Ireland) (XI) Austria (AT) France (FR) Spain (ES) Portugal (PT) Italy (IT) Sweden (SE) Poland (PL) Caspofungin Mylan Romania (RO) Germany (DE) Caspofungin Mylan 70 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung Netherlands (NL) Caspofungine Alenicum 70 mg poeder voor concentraat voor oplossing voor infusie
许可日期	2016/12/12
最近更新日期	2024/02/19
药物ATC编码	J02AX04 caspofungin
申请类型	TypeLevel1：Known Active Substance TypeLevel2：Multiple (Copy) Application TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final SPC \| MT_H_0218_001_DC_SPCDate of last change:2023/08/16 Final PL \| common-PL-70mgDate of last change:2021/01/12 Final Product Information \| common-combined-70mgDate of last change:2020/03/19 Final Product Information \| common-combined-50mgDate of last change:2020/03/19
市场状态	Positive